Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease
暂无分享,去创建一个
E. Wouters | G. J. van der Vusse | A. Schols | G. Schaart | E. Wouters | H. Gosker | G. Vusse | B. Kubat
[1] H. van Mameren,et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. , 2002, The American journal of clinical nutrition.
[2] H. van Mameren,et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[3] A. Ionescu,et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[4] S. Atiş,et al. Subclinical peripheral neuropathy associated with chronic obstructive pulmonary disease. , 2001, Electromyography and clinical neurophysiology.
[5] R. D. de Boer,et al. Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. , 2000, Journal of cardiac failure.
[6] R. Ferrari,et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes , 2000, Heart.
[7] K. O'rourke,et al. Myopathies in the elderly. , 2000, Rheumatic diseases clinics of North America.
[8] M. Decramer,et al. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. , 2000, The American journal of clinical nutrition.
[9] E. Wouters,et al. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. , 2000, The American journal of clinical nutrition.
[10] V. Edgerton,et al. Myonuclear domains in muscle adaptation and disease , 1999, Muscle & nerve.
[11] E. Wouters,et al. Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. , 1998, American Journal of Clinical Nutrition.
[12] D. McConkey,et al. Biochemical determinants of apoptosis and necrosis. , 1998, Toxicology letters.
[13] F. Maltais,et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[14] E. Wouters,et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.
[15] M. Decramer,et al. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[16] J. Mege,et al. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.
[17] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[18] E. Wouters,et al. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. , 1991, Thorax.
[19] S. Heymsfield,et al. Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. , 1990, The American journal of clinical nutrition.
[20] P. Mezin,et al. Microangiopathy of endoneurial vessels in hypoxemic chronic obstructive pulmonary disease (COPD) , 1989, Acta Neuropathologica.
[21] A. Miller,et al. Standardized lung function testing. , 1984, Bulletin europeen de physiopathologie respiratoire.
[22] M. Gardner,et al. Statistical guidelines for contributors to medical journals. , 1983, British medical journal.
[23] P. Wood,et al. Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps. , 1980, WHO chronicle.
[24] J. Rucker,et al. Binocular Diplopia: A Practical Approach , 2005, The neurologist.
[25] B. Make,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[26] R. B. Young,et al. Diseases and disorders of muscle. , 1993, Advances in food and nutrition research.
[27] Phillips Yy,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.